logo
  

Germany Private Sector Downturn Continues In November

Germany's private sector activity continued to remain in contraction in November, albeit the rate of decline eased as price pressures retreated from recent highs, flash survey data from S&P Global showed on Wednesday.

The flash composite output index rose to a 3-month low of 46.4 in November from 45.1 in August. The index was forecast to fall further to 44.9.

However, any reading below 50 indicates contraction in the sector.

At the sector level, manufacturing and services both reported sustained downturns in November, the survey said.

The services Purchasing Managers' Index fell to a 2-month low of 46.4 in November from 46.5 in the prior month. The score was forecast to drop to 46.2.

The manufacturing PMI rose to a 2-month high of 46.7 in November from 45.1 in October. The expected score was 45.0.

"Business confidence has steadied somewhat, with a mild autumn having perhaps allayed concerns about gas shortages over the winter," Phil Smith, a senior economist at S&P Global Market Intelligence said.

"Expectations have merely improved from ultra-low levels, meaning they are still rooted deeply in negative territory as firms continue to highlight concerns about the soaring cost of living, rising interest rates and still-high uncertainty."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT